Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
ARCA Biopharma Inc
ABIOCurrent price
1.84 USD
-0.04 USD (-2.13%)
Last closed
1.83 USD
Company
www.arcabio.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
26 370 484 USD
Yield for 12 month
-13.62 %
Week
Month
Year
ABIO
ARCA biopharma, Inc., a clinical development stage biopharmaceutical company, engages in the development and commercialization of genetically targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. It is also developing Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. The company was founded in 2004 and is headquartered in Westminster, Colorado. Address: 10170 Church Ranch Way, Westminster, CO, United States, 80021
Analytics
WallStreet Target Price
7 USDP/E ratio
–Dividend Yield
1.6 %Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures ABIO
1 year
3 years
5 years
10 years
EBITDA
-6 323 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-9.42 %
PEG Ratio
–
Return On Equity TTM
-13.44 %
Wall Street Target Price
7 USD
Revenue TTM
–
Book Value
2.64 USD
Revenue Per Share TTM
–
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
1.6 %
Gross Profit TTM
–
Earnings Share
-0.37 USD
Diluted Eps TTM
-0.37 USD
Most Recent Quarter
III 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ABIO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ABIO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
1.6 %
Last Split Factor
1:18
Payout Ratio
–
Last Split Date
04.04.2019
Dividend Date
04.04.2019
Stock Valuation ABIO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
1.6663
Price Book MRQ
0.6945
Financials ABIO
1 year
3 years
5 years
10 years
| Results | 2019 | Dynamics |
Technical indicators ABIO
For 52 weeks
1.74 USD
2.7 USD
50 Day MA
1.93 USD
Shares Short Prior Month
220 111
200 Day MA
2.03 USD
Short Ratio
8.74
Shares Short
214 435
Short Percent
2.08 %
Google
Apple
Facebook